Relay Therapeutics Inc (RLAY)

EBITDA Growth

-20.14%

Quarterly · Period ending:

RLAY logo

RLAY EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-20.14%
RLAY Quarterly EBITDA YoY % (-62.69% → -20.14%)
High-resolution chart · PNG

RLAY ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Relay Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-20.1433%
4.0471%
27.2921%
15.3762%
37.3681%
16.457%
19.6129%
-18.1491%
-3.6447%
10.0839%
-12.9626%
10.0286%
-39.4143%
-52.2181%
-26.5977%
-40.7379%
-32.7015%
-59.9118%
-279.4877%
-62.4307%
-115.1076%
-62.061%
244.8679%
-67.7823%
-39.7627%
-62.6883%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.